We are live on ! Find out more
BCM

Brookmont Capital Management Portfolio holdings

AUM $186M
1-Year Est. Return 10.11%
This Fund
S&P 500
This Quarter Est. Return
-2.8%
1 Year Est. Return
+10.11%
3 Year Est. Return
+36.63%
5 Year Est. Return
+48.26%
10 Year Est. Return
+211.29%
AUM
$183M
AUM Growth
-$7.32M
Cap. Flow
-$379K
Cap. Flow %
-0.21%
Top 10 Hldgs %
56.18%
Holding
56
New
5
Increased
7
Reduced
40
Closed
2

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$2.81M
2
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$430K
3
BIV icon
Vanguard Intermediate-Term Bond ETF
BIV
+$366K
4
BSV icon
Vanguard Short-Term Bond ETF
BSV
+$261K
5
GE icon
GE Aerospace
GE
+$247K

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$1.18M
2
DEO icon
Diageo
DEO
+$311K
3
IVV icon
iShares Core S&P 500 ETF
IVV
+$262K
4
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$234K
5
SHEL icon
Shell
SHEL
+$210K

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 33.33%
2 Financials 13.82%
3 Healthcare 11.25%
4 Technology 9.62%
5 Industrials 7.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HD icon
1
Home Depot
HD
$330B
$56.6M 30.98%
164,554
+464
+0.3% +$158K
AJG icon
2
Arthur J. Gallagher & Co
AJG
$64.9B
$5.79M 3.17%
22,323
+513
+2% +$127K
JPM icon
3
JPMorgan Chase
JPM
$938B
$5.68M 3.11%
28,085
-657
-2% -$128K
NVO
4
Novo Nordisk
NVO
$208B
$5.5M 3.01%
38,562
-646
-2% -$85.6K
WFC icon
5
Wells Fargo
WFC
$260B
$5.34M 2.92%
89,852
-2,524
-3% -$149K
MSFT icon
6
Microsoft
MSFT
$3.39T
$5.27M 2.88%
11,802
-285
-2% -$120K
SHEL icon
7
Shell
SHEL
$252B
$4.8M 2.63%
66,515
-2,945
-4% -$210K
HON icon
8
Honeywell
HON
$76.7B
$4.7M 2.57%
23,348
-807
-3% -$154K
ABT icon
9
Abbott
ABT
$181B
$4.59M 2.51%
44,137
-121
-0.3% -$12.8K
PG icon
10
Procter & Gamble
PG
$334B
$4.41M 2.41%
26,739
-453
-2% -$74.1K
DD icon
11
DuPont de Nemours
DD
$18.6B
$4.11M 2.25%
40,692
-1,588
-4% -$155K
MCD icon
12
McDonald's
MCD
$191B
$4.08M 2.23%
16,007
-270
-2% -$71.6K
CMCSA icon
13
Comcast
CMCSA
$84.5B
$3.99M 2.18%
101,884
-3,870
-4% -$151K
LHX icon
14
L3Harris
LHX
$50.7B
$3.87M 2.12%
17,229
-351
-2% -$75.8K
MCHP icon
15
Microchip Technology
MCHP
$40.8B
$3.83M 2.09%
41,849
-809
-2% -$74K
ACN icon
16
Accenture
ACN
$99B
$3.75M 2.05%
12,352
-171
-1% -$52.4K
COP icon
17
ConocoPhillips
COP
$145B
$3.66M 2%
31,976
-650
-2% -$78.9K
CVX icon
18
Chevron
CVX
$387B
$3.55M 1.94%
22,688
-91
-0.4% -$14.5K
ADI icon
19
Analog Devices
ADI
$179B
$3.48M 1.9%
15,237
-310
-2% -$66.1K
USB icon
20
US Bancorp
USB
$98B
$3.16M 1.73%
79,559
-2,768
-3% -$113K
GILD icon
21
Gilead Sciences
GILD
$162B
$3.1M 1.7%
45,196
-1,488
-3% -$99.3K
BAC icon
22
Bank of America
BAC
$435B
$3.08M 1.68%
77,441
-1,465
-2% -$56.1K
UPS icon
23
United Parcel Service
UPS
$89.2B
$3.01M 1.65%
22,028
-347
-2% -$49.7K
AZN icon
24
AstraZeneca
AZN
$264B
$2.91M 1.59%
+18,661
New +$2.81M
PEP icon
25
PepsiCo
PEP
$190B
$2.7M 1.47%
16,351
-263
-2% -$45.4K
1
2 3

Similar funds

SEP
Signature Equity Partners Columbus, Ohio $186M AUM
CC
Cederberg Capital London, United Kingdom $186M AUM 21.27% 1-Year Est. Return
BGA
Battery Global Advisors Boston, Massachusetts $186M AUM 15.74% 1-Year Est. Return
OBC
Oakum Bay Capital Westport, Connecticut $187M AUM
LPCM
Lynwood Price Capital Management Austin, Texas $186M AUM 5.63% 1-Year Est. Return
HC
Hurley Capital New York $187M AUM 23.24% 1-Year Est. Return
AC
AMANSA Capital Raffles City Tower, Singapore $187M AUM 38.38% 1-Year Est. Return
WWM
Whalen Wealth Management Las Vegas, Nevada $187M AUM 18.9% 1-Year Est. Return

Brookmont Capital Management's Q2 2024 Portfolio in Review

As of Q2 2024, Brookmont Capital Management held 56 positions worth $183M, down 3.9% from $190M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Brookmont Capital Management's Q2 2024 filing shows 5 new, 7 increased, 40 reduced and 2 closed positions. Its largest new stake was AstraZeneca: 18,661 shares worth $2.91M. The largest sale was Amgen, an estimated $1.18M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 33% of assets, down from 36% a quarter earlier, followed by Financials and Healthcare.

  • Brookmont Capital Management's largest Q2 2024 buy was AstraZeneca: 18,661 shares worth $2.91M.
  • Brookmont Capital Management added most to iShares Core US Aggregate Bond ETF in Q2 2024, an estimated $430K increase.
  • Brookmont Capital Management's biggest Q2 2024 reduction was Amgen, cutting an estimated $1.18M.
  • Brookmont Capital Management fully exited State Street SPDR S&P MIDCAP 400 ETF Trust in Q2 2024, selling an estimated $234K.
  • Brookmont Capital Management's ten largest holdings make up 56% of its $183M portfolio in Q2 2024.
  • Brookmont Capital Management opened 5 new positions and closed 2 in Q2 2024.
  • Brookmont Capital Management's portfolio value fell 3.9% quarter-over-quarter to $183M.

Based on Brookmont Capital Management's 13F filing for Q2 2024, filed 17 Jul 2024.